Sex-Specific Phenotypic Architecture in Cardiac Amyloidosis Identified by Explainable Machine Learning
BACKGROUND: Females are under-represented in cardiac amyloidosis (CA), but whether this reflects sex-associated phenotypic heterogeneity or differences in disease prevalence remains unclear. OBJECTIVES: The objectives of the study was to characterize sex-associated differences in presentation and prognosis across CA subtypes using unsupervised clustering. METHODS: We retrospectively analyzed 2,216 patients with confirmed CA enrolled between 2010 and 2022: light-chain amyloidosis (AL) (n = 583), variant transthyretin amyloidosis (ATTRv) (n = 432), and wild-type transthyretin amyloidosis (ATTRwt) (n = 1,201). Self-organizing maps with k-means partitioning were applied separately to each subtype, and conditional inference trees identified key phenotypic discriminators. RESULTS: Females represented 40.8%, 33.8%, and 15.9% of AL, ATTRv, and ATTRwt cohorts, respectively. Clustering identified 4 AL, 6 ATTRv, and 6 ATTRwt phenotypes. Across subtypes, female-predominant clusters generally showed preserved left ventricular ejection fraction, lower cardiac remodeling burden, and less pronounced biomarker elevation. Female-predominant AL clusters included preserved-function and multisystem profiles, whereas ATTRv clusters included neurologic-dominant and older cardiometabolic profiles. In ATTRwt, females were predominantly represented in a phenotype characterized by preserved systolic function and less structural remodeling. Conditional inference trees identified sex as the first discriminator in ATTRwt and a secondary discriminator in AL, whereas ATTRv clusters were primarily discriminated by cardiac variables and sex was not selected. CONCLUSIONS: Unsupervised clustering identified female-predominant phenotypes with less structural cardiac remodeling but distinct multisystem characteristics across CA subtypes. These findings support sex-associated phenotypic heterogeneity in CA and generate hypotheses regarding female underrepresentation in contemporary CA cohorts.
Authors
- Bianca Riccardi
- Emmanuel Itti (ORCID: https://orcid.org/0000-0003-1578-4058)
- Étienne Audureau (ORCID: https://orcid.org/0000-0002-6166-149X)
- Arnault Galat (ORCID: https://orcid.org/0009-0000-8260-143X)
- Charlotte Lafont (ORCID: https://orcid.org/0000-0002-5019-9914)
- Mounira Kharoubi (ORCID: https://orcid.org/0000-0001-8942-2506)
- Thibaud Damy (ORCID: https://orcid.org/0000-0003-4058-3848)
- Vincent Audard (ORCID: https://orcid.org/0000-0001-5343-2550)
- Emmanuel Teíger (ORCID: https://orcid.org/0000-0001-7515-4344)
- Silvia Oghina (ORCID: https://orcid.org/0000-0003-0108-5598)
- Amira Zaroui (ORCID: https://orcid.org/0000-0002-4827-4057)
Institutions
- Inserm (FR)
- Université Paris-Est Créteil (FR)
- Centre Hospitalier Universitaire Henri-Mondor (FR)
- Hôpitaux Universitaires Henri-Mondor (FR)
- Hôpital Albert-Chenevier (FR)
Publication Details
- Journal
- JACC Advances
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1016/j.jacadv.2026.103480
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Université Paris-Est Créteil Val-de-Marne